| 000 | 00947 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515230728.0 | ||
| 264 | 0 | _c20100909 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurst, Daniel E | |
| 245 | 0 | 0 |
_aDevelopment of TNF inhibitor therapies for the treatment of rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_aS5-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 28 _gno. 3 Suppl 59 _gp. S5-12 |
|
| 999 |
_c19924261 _d19924261 |
||